title: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.
authors.affiliation: Division of Gastroenterology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. keith.tolman@hsc.utah.edu
authors.forename: Keith G
authors.initials: KG
authors.lastname: Tolman
authors.forename: Vivian
authors.initials: V
authors.lastname: Fonseca
authors.forename: Anthony
authors.initials: A
authors.lastname: Dalpiaz
authors.forename: Meng H
authors.initials: MH
authors.lastname: Tan
mesh_terms: D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000145:classification* / Q000150:complications / Q000628:therapy; D005234:Fatty Liver / Q000150:complications / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008107:Liver Diseases / Q000145:classification* / Q000150:complications / Q000628:therapy; D008111:Liver Function Tests; D012449:Safety
chemical_list: D001549:Benzamides; D007004:Hypoglycemic Agents; C030516:meglitinide